Edgewise Therapeutics, Inc. EWTX Return on invested capital

Return on invested capital at other companies

Bristol-Myers SquibbBMY

16.7%+8.4pp

Dyne Therapeutics, Inc.DYN

-188.2%+14.8pp

Solid Biosciences Inc.SLDB

-112.5%-5.3pp

Capricor TherapeuticsCAPR

-83.2%-10.5pp

Scholar RockSRRK

-500.4%+7,305pp

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

FAQ

What is Edgewise Therapeutics, Inc.'s return on invested capital?

Edgewise Therapeutics, Inc. (EWTX) reported return on invested capital of -47.1% in Q1 2026.

How has Edgewise Therapeutics, Inc.'s return on invested capital changed year-over-year?

Edgewise Therapeutics, Inc.'s return on invested capital decreased by 23.7% year-over-year, from -38% to -47.1%.

What is the long-term trend for Edgewise Therapeutics, Inc.'s return on invested capital?

Over 2 years (2023 to 2025), Edgewise Therapeutics, Inc.'s return on invested capital has grown at a 3.4% compound annual growth rate (CAGR), from -40.3% to -43.1%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.